• PharmaDrug (BUZZ) announced the company is changing it stock ticker symbol later this year
  • The Toronto specialty pharmaceutical company will begin using the symbol “PHRX” on the Canadian Securities Exchange
  • The company expects the change to take place on August 3rd
  • The new ticker symbol better aligns with the company’s long-term vision
  • PharmaDrug is down 8.33 per cent, trading at $0.055 at 12:30 pm ET

PharmaDrug (BUZZ) announced the company is changing it stock ticker symbol later this year.

The Toronto specialty pharmaceutical company will begin using the symbol “PHRX” on the Canadian Securities Exchange.

The company expects the change to take place on August 3rd.

The change in the ticker symbol is being made to provide greater visibility given the company’s long-term strategy.

“We are looking forward to trading under the new ‘PHRX’ symbol on the Canadian Stock Exchange. The new symbol directly aligns with the vision of the company and the path we foresee taking in order to continue adding significant value to our shareholders by developing and commercializing naturally derived medicines,” said PharmaDrug Chairman and CEO Daniel Cohen.

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs.

The company owns 80 per cent of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU.

Pharmadrug Inc. (BUZZ) is down 8.33 per cent, trading at C$0.055 per share at 12:30 pm ET.

More From The Market Online

CCrest Labs receives Red Light Holland’s largest psilocybin order

Red Light Holland's (CSE:TRIP) largest shipment to date of 5 kilograms of psilocybin truffles has been received by CCrest Labs in Montreal.

Red Light Holland reports record psilocybin shipment

Psychedelics stock Red Light Holland (CSE:TRIP) exports 5 kilograms of natural psilocybin truffles to CCrest Laboratories in Montreal.

Psychedelic stock begins take-home LSD microdosing clinical trial

MindBio Therapeutics (CSE:MBIO) secures approvals for MB22001 – a form of LSD – microdosing use by patients in a controlled clinical trial.

Red Light Holland begins experimental research on psilocybin truffles

Red Light Holland has revealed that it has officially begun an experimental research project on its psilocybin truffles.